Stephen Robinson (he/him) 🏳️‍🌈

Research Group Leader at The Quadram Institute and Senior Lecturer at the University of East Anglia.

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@biorxiv_cellbio Very excited about our latest work

[bioRxiv Cell Biology @biorxiv_cellbio]

Neuropilin 2 stabilises adherens junctions and protects against endothelial activation by promoting the interaction between VE ... https://t.co/DlziSwps2I #biorxiv_cellbio

[Mark Morgan's Lab @M_MorganLab]

Very excited to share our latest paper describing crosstalk between αvβ6 integrin & HER2 in breast cancer invasion & drug resistance.
Great work by @HJMald & many others
https://t.co/PdTG1XsPZE
@ScienceAdvances @LivUniISMIB @AdamHurlstone Many thanks to @BCCare @NorthWestCancer

[nteng @nteng18]

Paper from my #PhD is out! We profiled the gut and oral #microbiome of metastatic #breastcancer patients. This project was a long one in collaboration with @wearemedsir. Thanks @TheQuadram @bigctweets for supporting my studentship. It's published 🎉.

https://t.co/cYXNwRrnJz

[Daniel Figeys @DanielFigeys]

Delighted to share that I’ll be joining the @QuadramInstitute as Director & CEO in April 2025! I am honoured to work with an incredible team and partners to push the boundaries of gut health, microbiology, and food science research.

[Hall Lab @hall_lab]

🥳I'm incredibly honoured to receive the @MicrobioSoc Peter Wildy Prize 2025 for #scicomm, a true team prize! Huge thanks to those who nominated me & to incredible collaborators & team members. So many people to thank - I'll be highlighting them all in my prize lecture!🦠

[Hall Lab @hall_lab]

🚨 Exciting opportunity at @unibirmingham @unibirm_CMH! 🚨 Offering a 2-year Springboard Fellowship designed to support high-calibre #PDRA researchers in developing strong proposals for fellowships like ERC Starter Grants, Future Leaders Fellowship, Wellcome/MRC CDA, and more.

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@ThrashTalk @Yale Whhooooo

[Hall Lab @hall_lab]

Check out this exciting thread featuring a new preprint from @RobinsonLab_QIB 👇
Thrilled to share our collaborative study on #Bifido and #BreastCancer, now preprinted! We explore the "sweet spot" of EPS-driven #anticancer immune mechanisms. #GutHealth #CancerResearch

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

Check out the full preprint for more details! 🧬 #cancerimmunology:
https://t.co/wBGPASmlML

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

🧵 Exciting new preprint! 🚨 We’ve uncovered how Bifidobacterium pseudocatenulatum capsular exopolysaccharides (EPS) can enhance systemic anti-tumour immunity in pre-clinical breast cancer models. Here's what we found 👇 #cancerresearch #microbiome

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

3/ Think of it as bacteria with a “sweeter” edge - the sugars in the EPS are driving immune responses that fight tumours. This unique mechanism positions Bifidobacterium EPS as a potential new class of therapeutic compounds in cancer treatment. 💥 #immunotherapy

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@MrSharkey @phillipthesmall Cuuuute

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@chrtucci Beautiful

[Hall Lab @hall_lab]

SO pleased to see this study now published @MolMetab - led by the fantastic @JLopTello! Jorge is currently setting up his own lab @UAM_Medicina so definitely keep an 👀out for further exciting work in this area and research opportunities!

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@DHefferle If you want to venture outside of London, you are welcome in Norwich

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@philford 😂

[Stephen Robinson (he/him) 🏳️‍🌈 @RobinsonLab_QIB]

@captainiberia 😂😂